Sabby Management, LLC Neuro Bo Pharmaceuticals, Inc. Transaction History

Sabby Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $0.9 $111,894 - $251,761	-279,735 Reduced 74.97%	93,376 $45,000
Q1 2022 May 16, 2022	SELL	$0.72 - $1.54 $240,361 - $514,105	-333,835 Reduced 47.22%	373,111 $337,000
Q4 2021 Feb 14, 2022	BUY	$1.22 - $2.5 $862,474 - $1.77 Million	706,946 New	706,946 $862,000
Q1 2021 May 17, 2021	SELL	$3.93 - $6.68 $559,632 - $951,232	-142,400 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.02 - $6.59 $201,517 - $264,542	-40,143 Reduced 21.99%	142,400 $748,000
Q3 2020 Nov 16, 2020	SELL	$5.41 - $8.67 $270,521 - $433,534	-50,004 Reduced 21.5%	182,543 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$8.05 - $29.44 $1.87 Million - $6.85 Million	232,547 New	232,547 $1.87 Million

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.